The present invention is directed generally to pharmaceutical compositions,methods, and kits for improving side effects associated with aromataseinhibitor treatment in a subject diagnosed with breast cancer. Morespecifically, the present invention provides compositions, methods, and kitscomprising an aromatase inhibitor and an androgenic agent.